Tech Company Financing Transactions
Mpex Pharmaceuticals Funding Round
On 2/10/2009, Mpex Pharmaceuticals raised $27.5 million in Series D investment from private investors.
Transaction Overview
Company Name
Announced On
2/10/2009
Transaction Type
Venture Equity
Amount
$27,500,000
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11535 Sorrento Valley Road
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Burgess
Chief Medical Officer
Jeffery Loutit
Vice President
Scott Hecker
Vice President
Olga Lomovskaya
VP - Operations
Elizabeth Morgan
VP - R & D
Michael Dudley
Browse more venture capital transactions:
Prev: 2/10/2009: Omni-ID venture capital transaction
Next: 2/10/2009: PivotLink venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs